Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C3H7N3O4 |
Molar mass | 149.106 g·mol−1 |
3D model ( JSmol) | |
| |
| |
(verify) |
Alanosine (also called SDX-102) [1] is a substance that has been studied for the treatment of pancreatic cancer. [2] It is an antimetabolite. It is used as one of a few experimental treatments for patients with deadly pancreatic cancer when the main chemotherapeutic treatment regimen of gemcitabine is no longer useful.[ needs update]